Arvinas Inc. is a biopharmaceutical company focused on the development and commercialization of therapies based on targeted protein degradation to treat patients with cancers and other difficult-to-treat diseases.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!